KR920701200A - 신규의 4h-3,1-벤조옥사진-4-온 유도체 - Google Patents

신규의 4h-3,1-벤조옥사진-4-온 유도체

Info

Publication number
KR920701200A
KR920701200A KR1019910701719A KR910701719A KR920701200A KR 920701200 A KR920701200 A KR 920701200A KR 1019910701719 A KR1019910701719 A KR 1019910701719A KR 910701719 A KR910701719 A KR 910701719A KR 920701200 A KR920701200 A KR 920701200A
Authority
KR
South Korea
Prior art keywords
group
lower alkyl
alkyl group
alkyl
benzooxazin
Prior art date
Application number
KR1019910701719A
Other languages
English (en)
Inventor
고오지 고바야시
고오이 오자와
마사시 사사부찌
이츠오 우찌다
Original Assignee
미즈노 시게루
니혼다바고 상교오 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미즈노 시게루, 니혼다바고 상교오 가부시기가이샤 filed Critical 미즈노 시게루
Publication of KR920701200A publication Critical patent/KR920701200A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

신규의 4H-3,1-벤조옥사진-4-온 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 하기 일반식(Ⅰ)로 나타내는 4H-3,1-벤조옥사진-4-온 유도체.
    (상기 식중, R1은 저급알킬기를 의미하며, R2는 저급알킬기, 저급알킬-티오-알킬기 또는 저급알칸술피닐알킬기를 의미하며, R3는 수소원자, 수산기, 저급알콕시기 또는 저급아시록시기를 의미하며, X는 아라닌, 발린, 페닐아라닌으로 이루어지는 군에서 선택되는 아미노산잔기를 의미하며, n은 0,1 또는 2의 정수를 의미하며, Y는 페닐기로 치환되어도 되는 산소원자수 2 내지 6의 알카노일기, 벤졸-옥시-카르보닐기, 저급알콕시카르보닐기, 신나모일기 및 메톡시숙시닐기로 이루어지는 군에서 선택되는 치환기를 의미한다).
  2. 하기 일반식(F)으로 나타내는 중간체화합물.
    (상기 식중, R1은 저급알킬기를 의미하며, R2는 저급알킬기, 저급알킬-티오-알킬기 또는 저급알칸술피닐 알킬기를 의미하며, R3는 수소원자, 수산기, 저급알콕시기 또는 저급아시록시기를 의미하며, X는 아라닌, 발린, 페닐아라닌으로 이루어지는 군에서 선택되는 아미노산잔기를 의미하며, n은 0,1 또는 2의 정수를 의미하며, Y는 페닐기로 치환되어도 되는 산소원자수 2내지 6의 알카노일기, 벤졸-옥시-카르보닐기, 저급알콕시카르보닐기, 신나모일기 및 메톡시숙시닐기로 이루어지는 군에서 선택되는 치환기를 의미한다).
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910701719A 1990-03-30 1991-03-26 신규의 4h-3,1-벤조옥사진-4-온 유도체 KR920701200A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8067490 1990-03-30
JP90-80674 1990-03-30
PCT/JP1991/000386 WO1991015487A1 (fr) 1990-03-30 1991-03-26 Nouveau derive de 4-1-benzoxazine-4h-3,1

Publications (1)

Publication Number Publication Date
KR920701200A true KR920701200A (ko) 1992-08-11

Family

ID=13724902

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701719A KR920701200A (ko) 1990-03-30 1991-03-26 신규의 4h-3,1-벤조옥사진-4-온 유도체

Country Status (5)

Country Link
US (1) US5204462A (ko)
EP (1) EP0480044A4 (ko)
KR (1) KR920701200A (ko)
CA (1) CA2056453A1 (ko)
WO (1) WO1991015487A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200143394A (ko) * 2018-04-11 2020-12-23 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 디시아노알칸 및 비스(아미노메틸)알칸의 제조방법

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332734A (en) * 1991-04-10 1994-07-26 Japan Tobacco, Incorporated Oxazinone derivative
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
KR100367389B1 (ko) * 1994-06-02 2003-07-18 메렐 파마슈티칼스 인크. 엘라스타제억제제의프로드러그로서아실화에놀유도체
AU690986B2 (en) * 1994-06-02 1998-05-07 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
KR20010012316A (ko) * 1997-05-08 2001-02-15 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 프로테아제 억제제
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
JP2003535022A (ja) 1998-06-03 2003-11-25 コーテック インコーポレーテッド セリンプロテアーゼ阻害剤としてのアルファー‐ケトオキサジアゾール含有ペプトイド及び非ペプトイド
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
JPWO2002055073A1 (ja) * 2001-01-05 2004-05-13 協和醗酵工業株式会社 関節炎の予防剤
US6555095B1 (en) 2001-12-14 2003-04-29 Avon Products, Inc. Topical compositions and methods of application
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
WO2004080283A2 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644350A (en) * 1969-07-07 1972-02-22 Robins Co Inc A H 4-(1-substituted-3-pyrrolidinyl)-2h-1 4-benzoxazin-3(4h)-ones
CH550060A (de) * 1972-03-01 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von polyestertiefziehformteilen.
JPS58185644A (ja) * 1982-04-23 1983-10-29 Daicel Chem Ind Ltd ポリマ−組成物
JPS60169469A (ja) * 1983-12-27 1985-09-02 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド ４ｈ−１，３−ベンズオキサジン−４−オン化合物
US4657893A (en) * 1984-05-09 1987-04-14 Syntex (U.S.A.) Inc. 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
US4745116A (en) * 1985-06-25 1988-05-17 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
JP3458400B2 (ja) * 1993-01-29 2003-10-20 松下電器産業株式会社 電子楽器用鍵盤装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200143394A (ko) * 2018-04-11 2020-12-23 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 디시아노알칸 및 비스(아미노메틸)알칸의 제조방법

Also Published As

Publication number Publication date
EP0480044A4 (en) 1993-06-09
US5204462A (en) 1993-04-20
CA2056453A1 (en) 1991-10-01
EP0480044A1 (en) 1992-04-15
WO1991015487A1 (fr) 1991-10-17

Similar Documents

Publication Publication Date Title
KR920701200A (ko) 신규의 4h-3,1-벤조옥사진-4-온 유도체
KR960704919A (ko) 신규인 펩티드 유도체 (novel peptide derivative)
CA2152819A1 (en) New antiparasitic agents related to the milbemycins and avermectins
KR890002198A (ko) 유기 규소 화합물
KR890011884A (ko) 캠프토데신 유도체
ES2142582T3 (es) Organosilicona que tiene un grupo funcional carboxilo.
KR910016742A (ko) 알킬화된 옥소-피페라진일-트리아진
KR930702254A (ko) 아닐리드 유도체
KR900004820A (ko) 안정화된 합성수지조성물
KR860700250A (ko) 신규 아미딘 화합물
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
KR920702685A (ko) 4,6-o- 히드록시포스포릴글루코사민 유도체
KR910018372A (ko) 에테르 결합을 갖는 페닐시클로헥실디옥산 유도체
KR870004038A (ko) 제초제 화합물의 제조방법
KR890012949A (ko) O-아실아미드옥심 유도체
KR930700456A (ko) 헥사히드로피리다진-1,2-디카르복시 유도체의 제조방법
CO4790086A1 (es) Composiciones repelentes de insectos que comprenden mezclas de una n-alquil neoalcanamida y n,n-dietil-meta-toluamida y procesos de utilizacion
KR920002706A (ko) 혐기 경화성 조성물
KR880012688A (ko) 자외선 경화형 수지 조성물
KR900016184A (ko) 1, 3-디옥산 유도체
KR950000704A (ko) 로라카베프 하이드로클로라이드 c_1-c_3 알콜 용매화물 및 그의 용도
KR920009772A (ko) 트리아릴메탄 화합물 및 압력 민감성 기록재료
KR930700433A (ko) 신규 디술피드 화합물
KR920009818A (ko) 신규 벤조디옥솔 유도체 및 이를 함유하는 간장해 개선제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application